Boning Up on Pfizer's Drug

Boning Up on Pfizer's Drug

Motley Fool - 20 minutes ago

By Brian Orelli The newest data on Pfizer's (NYSE: PFE) Fablyn, which was published in yesterday's New England Journal of Medicine, won't help the drug get approved -- the company still needs to ...

http://bit.ly/cRT5t1